ACVN Nutrition Notes , Nutrition , Urology/Renal Medicine

Nutritional Management of Renal Disease: An Evidence-Based Approach

  •  
  •  
  •  
  •  
  •  
  •  
  •  

pdf_button


Sherry Lynn Sanderson, DVM, PhD, Diplomate ACVIM & ACVN

University of Georgia

Successful treatment of chronic kindney disease involves a multi-modal approach to identify and eliminate exacerbating factors together with implementation of veterinary therapeutic renal diets and medical management.


Today’s Veterinary Practice is delighted to announce that the American College of Veterinary Nutrition (acvn.org) has partnered with TVP to bring our readers the NUTRITION NOTES column.

The primary objectives of the ACVN are to:

  • Advance the specialty area of veterinary nutrition
  • Increase the competence of those practicing in this field
  • Establish requirements for certification in veterinary nutrition
  • Encourage continuing education for both specialists and general practitioners
  • Promote evidence-based research
  • Enhance dissemination of the latest veterinary nutrition knowledge.

The ACVN achieves these objectives in many ways, including designating specialists in animal nutrition, providing continuing education through several media, supporting veterinary nutrition residency programs, and offering a wide array of resources related to veterinary nutrition.

By bringing this column to TVP readers, the ACVN is reaching out to all veterinary professionals to provide the highest quality, cutting edge information on companion animal nutrition, contributed by their foremost nutrition specialists.

Chronic kidney disease (CKD) is the most common type of renal disease in senior patients, but can occur in animals of all ages. Estimated incidence of CKD in all dogs and cats is 0.5% to 1.5%, respectively, and, in cats over 15 years of age, 30%.1 In senior patients, CKD commonly results in morbidity and mortality.2

CKD is defined as the presence of structural or functional abnormalities of one or both kidneys that have been present for an extended period of time, usually 3 months or longer. It is characterized by irreversible and progressive loss of kidney function, leading to azotemia, uremia, and clinical signs associated with diminishing renal function.

A uremic crisis is defined as a patient having at least 2 of the following clinical signs: depression, lethargy, anorexia, vomiting, ammonia breath odor, or uremic stomatitis.

Successful treatment of CKD requires a multi-modal approach, which involves identifying and eliminating exacerbating factors, combined with appropriate dietary and medical management.3-5

EVIDENCE-BASED THERAPIES

Many therapeutic interventions have been developed or advocated for management of CKD; however, evidence of efficacy or effectiveness of these interventions is often lacking or highly variable. If current recommendations undergo the scrutiny of evidence-based medicine, very few meet the criteria to receive a Grade I designation (Table 1).

Dietary management of CKD is one of the few current recommendations for management of CKD in dogs and cats that has Grade I evidence.4-9 As a result, dietary management remains the cornerstone of therapy for CKD.

Screen Shot 2015-06-18 at 4.33.56 PM

COMPARISON OF DIETARY THERAPIES

Research has shown that, for managing CKD in dogs and cats, veterinary therapeutic renal diets are superior to maintenance diets (Table 2).4,6-9

Although these studies in both dogs and cats demonstrate that feeding a therapeutic renal diet to patients with CKD is superior to feeding a maintenance diet, the diets in these studies varied in many of the key nutrients for management of CKD, including dietary protein, phosphorus, and fatty acid composition. Therefore, it is unknown which component(s) of the therapeutic renal diets resulted in the benefits observed in these studies.

NN-2

 

KEY NUTRIENTS IN DIETARY MANAGEMENT

Commercial therapeutic renal diets vary in their nutritional composition; turn to page 53 for tables detailing the nutritional composition of these diets.

In the cats in Study 4 (Table 2), median survival time was longest in cats fed the diet with the highest eicosapentaenoic acid (EPA) content and one of the highest potassium levels. Survival times were lowest for the diet not supplemented with EPA and the lowest potassium content.8 Unfortunately, the identity of the therapeutic renal diets evaluated in this study was not provided, and it is likely that diet composition has changed since this study was published.

The majority of work performed to determine which nutrients are beneficial at what levels in the management of CKD has been done in dogs. The remainder of this article will focus on research results from these studies.

Phosphorus

A study was conducted in dogs to determine the effects of high (H) and low (L) levels of dietary phosphorus and protein on renal function and survival in adult dogs with induced CKD.10

  • Four diet groups (n = 12/group) were fed one of 4 experimental diets for 24 months after surgical reduction of renal mass.
  • The experimental diets (Table 3) contained varying levels of protein and phosphorus listed on a percent dry matter basis (DMB). Diet 4 was most consistent with many veterinary therapeutic renal diets.
  • Results showed that:
    • When renal function was reduced to the point that moderate azotemia (serum creatinine, 3–4 mg/dL) occurred, dietary phosphorus restriction was associated with a longer period of stable glomerular filtration rate (GFR) and improved survival.
    • Dogs fed high dietary protein had no functional or morphologic evidence of adverse effects compared with dogs fed low dietary protein.

Therefore, this study showed that survival of dogs with induced CKD was enhanced by phosphorus restriction but not by protein restriction.

Screen Shot 2015-06-18 at 4.34.12 PM

Omega-3 Polyunsaturated Fatty Acids

Dogs lack the ability to synthesize omega-6 and omega-3 polyunsaturated fatty acids (PUFAs); therefore, they are considered dietary essential fatty acids.11

  • Dogs require linoleic acid (LA), an omega-6 PUFA, and have the enzyme capability to convert linoleic acid into arachidonic acid (AA), another omega-6 PUFA.
  • However, dogs are unable to convert omega-6 PUFAs into omega-3 PUFAs.
  • Not all omega-3 PUFAs are metabolically equivalent:
  • Plant-based sources of omega-3 PUFAs, such as flaxseed, linseed, and canola oil, are rich in alpha-linolenic acid (ALA).
  • Marine algae and oily cold water fish are good sources of EPA and docosahexaenoic acid (DHA).

Conversion Rates. While LA is readily converted to AA, ALA converts to EPA and DHA much more slowly. This conversion rate is < 10% in humans, and believed to be rather limited in dogs as well.12

Omega-3 PUFA Benefits. While dietary ALA has some benefits in healthy dogs and management of some dermatologic diseases,13 the majority of therapeutic benefits from omega-3 fatty acids result from:

  • EPA: Anti-inflammatory and prostaglandin effects
  • DHA: Central nervous system development and retinol function, which are critical during pregnancy and early life.

These omega-3 PUFAs are used in dietary management of kidney disease, cardiovascular disease, idiopathic hyperlipidemia, inflammatory and immune diseases, and osteoarthritis.11-13

Therefore, when using omega-3 PUFAs for dietary management of medical conditions, the source should also already contain EPA and DHA because the conversion rate of ALA to EPA and DHA may be too slow to benefit the patient.

Additional Benefits. When nephrons are destroyed in CKD, the remaining viable nephrons hypertrophy in an attempt to compensate, resulting in a maladaptive increase in glomerular capillary pressure (GCP). Dietary omega-3 fatty acid supplementation in the form of fish oil can have beneficial effects in reducing GCP.

In studies by Brown, et al,14-16 the effects of various dietary omega-6:omega-3 ratios on glomerular hypertension in a canine remnant kidney model were evaluated.

  • Three groups of 6 dogs were fed diets with omega-6:omega-3 ratios of 50:1, 25:1, and 5:1 for 10 weeks.
  • Omega-3 PUFA supplementation was supplied in the form of fish oil, which is rich in EPA and DHA.
  • Results showed the omega-6:omega-3 diet with the 5:1 ratio normalized GCP in dogs with reduced kidney function to a level consistent with that found in dogs with normal kidney function.

Antioxidants

A free radical is any atom or molecule that has a single unpaired electron. Normal aerobic metabolism, along with many environmental factors, contributes to the formation of reactive oxygen species (ROS) in the body. ROS can damage membrane lipids, nucleic acids, and proteins in the body that, in turn, contribute to disease processes.

Oxidative Stress. Normally, antioxidant defense mechanisms adequately remove ROS as they are formed; however, these mechanisms become inadequate as animals age, and progressive oxidative damage is a consistent feature of aging unless adequate dietary sources of antioxidants are provided. Keep in mind, though, that oversupplementation of dietary antioxidants may be as detrimental as deficiency of dietary antioxidants.

Since CKD occurs most commonly in older dogs:

  • Oxidative stress can be a contributing factor to the decline in GFR associated with CKD.
  • Renal oxidative stress is a problem because surviving hypertrophied nephrons become adaptively hyperfunctional, leading to a dramatic increase in cellular oxidative phosphorylation.16

Optimum Supplementation. In a study by Brown,16 the effects of omega-3 fatty acid and antioxidant supplementation were evaluated separately and in combination in 6- to 8-year-old beagle dogs with induced CKD. Four groups of 8 dogs were fed one of 4 diets (Table 4).

Screen Shot 2015-06-18 at 4.34.18 PM

The results demonstrated that veterinary therapeutic renal diets supplemented with omega-3 PUFAs from fish oil in combination with antioxidants appear to better slow progression of CKD than diets supplemented with only one or the other or none at all.

Protein

The traditional approach to dietary management of CKD in dogs was reduction of protein intake to less than the minimum levels for adult maintenance (18% DMB) recommended by the Association of American Feed Control Officials (AAFCO). The rationale for this approach considered that:

  • Reduced protein diets decrease production of nitrogenous waste products excreted by the kidneys
  • Protein is one of the major contributors to phosphorus in the diet; reduction of dietary protein also reduces dietary phosphorus levels, which has shown benefit in management of CKD in dogs.10

Amount of Dietary Protein. However, reduced dietary protein for management of CKD in dogs is not necessarily beneficial.

  1. Senior dogs are less efficient at metabolizing dietary protein than younger dogs and, thus, require more dietary protein to maintain protein reserves and maximize protein turnover rates.17,18
  2. In humans, loss of lean body mass often accompanies dietary protein restriction, and can result in loss of physical strength, motor coordination, and impaired immune function.19,20
  3. Loss of lean body mass has also been associated with increased rates of morbidity and mortality in humans, and a similar result was observed in a study in dogs (Table 5).21
  4. Work by Finco and Brown10 demonstrated that dietary phosphorus restriction, but not dietary protein restriction, was beneficial in dogs with CKD.
  5. In a study by Kealy,21 26 healthy pointers, ages 7 to 9 years, were fed a 16.5% or 45.6% protein diet for 2 years. The results of the study are outlined in Table 5.

Screen Shot 2015-06-18 at 4.34.24 PM

Recently, it has been shown that dietary protein levels can be increased in dogs with CKD without adversely affecting life expectancy. However, the diet must be phosphorus restricted, using protein sources naturally lower in phosphorus concentration, such as soy isolate.5

Enteric Dialysis. In addition, by using nonrenal methods of excreting urea from the body, such as enteric dialysis, it may be possible to increase dietary protein fed to dogs with CKD without increasing nitrogen excretion burden on the kidneys. To promote enteric dialysis, diets can be supplemented with certain types of fermentable fiber, such as beet pulp, fructooligosaccharide (FOS), and gum arabic.

010214 NN ent dial

A study evaluated 12 healthy adult dogs that, for 14 days, were fed either a normal maintenance diet or the same diet supplemented with a fermentable fiber blend, which included beet pulp, FOS, and gum arabic.22 Dogs fed the diet containing the fermentable fiber blend had increased fecal nitrogen excretion (34% increase; p < 0.05) and decreased urinary nitrogen excretion. Therefore, it appears the body increased nitrogenous waste product excretion via a nonrenal mechanism; this mechanism could be used to potentially increase dietary protein intake in dogs with CKD, without increasing buildup of uremic toxins.

010214 NN enc pts

IN SUMMARY

The mainstay of therapy for CKD—in both dogs and cats—is dietary management. Research has shown that:

  • Veterinary therapeutic renal diets are superior to conventional maintenance diets for management of CKD.
  • Diets containing omega-3 PUFAs in the form of fish oil and rich in EPA are beneficial for both dogs and cats.
  • Renal diets supplemented with appropriate amounts of antioxidants are beneficial for dogs.
  • Most recently, dietary protein restriction in dogs with CKD may be unnecessary as long as the diet fed is phosphorus restricted and supplemented with prebiotic fiber to promote enteric dialysis.5

It is important to keep in mind, though, that commercial therapeutic renal diets vary in their nutritional composition.

010214 NN food table copy

AA = arachidonic acid; AAFCO = Association of American Feed Control Officials; ALA = alpha-linolenic acid; CKD = chronic kidney disease; DMB = dry matter basis; EPA = eicosapentaenoic acid; FOS = fructooligosaccharide; GCP = glomerular capillary pressure; GFR = glomerular filtration rate; H = high; L = low; LA = linoleic acid; PUFA = polyunsaturated fatty acid; ROS = reactive oxygen species; SCFA = short-chain fatty acid

References

  1. Krawiec DR, Gelberg HB. Chronic renal disease in cats. In Kirk RW (ed): Current Veterinary Therapy X: Small Animal Practice. Philadelphia: Saunders, 1989, pp 1170-1173.
  2. Polzin DJ. Chronic kidney disease. In Bartges J, Polzin DJ (ed): Nephrology and Urology of Small Animals. Ames, IA: Wiley-Blackwell, 2011, pp 433-477.
  3. Roudebush P, Polzin DJ, Adams LG, et al. An evidence-based review of therapies for canine chronic kidney disease. J Small Anim Pract 2010; 51:244-252.
  4. Jacob F, Polzin DJ, Osborne CA, et al. Clinical evaluation of dietary modification for treatment of spontaneous chronic renal failure in dogs. JAVMA 2002; 220:1163-1170.
  5. Sanderson SL, Tetrick M, Brown SA, et al. Effect of dietary approach on clinical outcome measures in dogs with naturally occurring chronic kidney disease (abstract). AAVN Symp Proc 2013; p 9.
  6. Parker VJ, Freeman LM. Association between body condition and survival in dogs with acquired chronic kidney disease. J Vet Intern Med 2011; 25:1306-1311.
  7. Ross SJ, Osborne CA, Kirk CA, et al. Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats. JAVMA 2006; 229:949-957.
  8. Plantinga EA, Everts H, Kastelein AMC, et al. Retrospective study of the survival of cats with acquired chronic renal insufficiency offered different commercial diets. Vet Rec 2005; 157:185-187.
  9. Elliott J, Rawlings JM, Markwell PJ, et al. Survival of cats with naturally occurring chronic renal failure: Effect of dietary management. J Small Anim Pract 2000; 41:235-242.
  10. Finco DR, Brown SA, Crowell WA, et al. Effects of dietary phosphorus and protein in dogs with chronic renal failure. Am J Vet Res 1992; 53:2264-2271.
  11. Bauer JE. New insights and existing perceptions on fish oil omega-3 fatty acids in companion animal clinical practice. NAVC Conf Proc 2013.
  12. Lenox CE, Bauer JE. Potential adverse effects of omega-3 fatty acids in dogs and cats. J Vet Intern Med 2013; 27:217-226.
  13. Mueller RS, Fettman MJ, Richardson K, et al. Plasma and skin concentrations of polyunsaturated fatty acids before and after supplementation with n-3 fatty acids in dogs with atopic dermatitis. Am J Vet Res 2005; 66:868-873.
  14. Brown SA, Brown CA, Crowell WA, et al. Beneficial effects of chronic administration of dietary omega-3 polyunsaturated fatty acids in dogs with renal insufficiency. J Lab Clin Med 1998; 131:447-455.
  15. Brown SA, Brown CA, Crowell WA, et al. Effects of dietary polyunsaturated fatty acid supplementation in early renal insufficiency in dogs. J Lab Clin Med 2000; 135:275-286.
  16. Brown SA. Oxidative stress and chronic kidney disease. Vet Clin Small Anim 2008; 38:157-166
  17. Wannemacher RW, McCoy JR. Determination of optimal dietary protein requirements of young and old dogs. J Nutr 1966; 88:66-74.
  18. Evan WJ, Campbell WW. Sarcopenia and age-related changes in body composition and functional capacity. J Nutr 1993; 123:465-468
  19. Castaneda C, Charnley JM, Evans WJ, et al. Elderly women accommodate to a low-protein diet with losses of body cell mass, muscle functions, and immune response. Am J Clin Nutr 1995; 62:30-39.
  20. Baumgartner RN, Koehler KM, Romero L, et al. Serum albumin is associated with skeletal muscle in elderly men and women. Am J Clin Nutr 1996; 64:552-558.
  21. Kealy RD. Factors influencing lean body mass in aging dogs. Purina Nutrition Forum Proc 1998; pp 34-37.
  22. Howard MD, Sunvold GD, Reinhart GA, et al. Effect of fermentable fiber consumption by the dog on nitrogen balance and fecal microbial nitrogen excretion. FASEB J 1996; 10:A257.

Sherry Lynn SandersonSherry Lynn Sanderson, BS, DVM, PhD, Diplomate ACVIM & ACVN, is an associate professor in the University of Georgia College of Veterinary Medicine specializing in nutritional management of diseases. She received her DVM and PhD from University of Minnesota.

DMCA.com Protection Status
MENU